Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Myasthenia Gravis × Alkalies × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 1 Neoplasms 1 Myasthenia Gravis 1 Disease 1

Interventions

Rituximab 6 Pyridostigmine Bromide 5 Prednisone 5 Hizentra 4 telitacicept 3 efgartigimod alfa 3 thymoglobulin 2 Thymectomy 2 Steroids 2 Immunoglobulins, Intravenous 2 Data Collection 2 Cyclophosphamide 2 Blood Specimen Collection 2 Azathioprine 2 zilucoplan 1 tofacitinib 1 tocilizumab 1 sargramostim 1 prednylidene 1 gamma-Globulins 1 fludarabine 1 deltacortene 1 carmustine, poliferprosan 20 drug combination 1 bu-zhong-yi-qi-tang 1 apraclonidine 1 Walk Test 1 Tacrolimus 1 Tablets 1 Sugars 1 Sugammadex 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05919407 2023-06-26

IMPACT-MG

Leiden University Medical Center

Phase 3 Unknown

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡